Evaluation of Quality of Life in Patients With Type 1 Diabetes Mellitus During the Covid-19 Pandemic

Study Overview
=================
Brief Summary
-----------------
During the COVID-19 pandemic, the time spent at the home of patients has increased because of national quarantine policies and patients' fear of getting sick. For this reason, in this ongoing process, patients have been unable to go to work regularly due to their chronic diseases (being on administrative leave) and their fear of going out. These reasons have prevented being physically active. The aim of the study is to evaluate the physical activity level, quality of life, glucose control, anxiety, depression, fear of hypoglycemia and loneliness perceptions of patients with type 1 diabetes mellitus during the COVID-19 pandemic period and compared with healthy controls.

Official Title
-----------------
Evaluation of Quality of Life, Physical Activity and Depression in Patients With Type 1 Diabetes Mellitus During the Covid-19 Pandemic

Conditions
-----------------
Type 1 Diabetes Mellitus, Covid19

Intervention / Treatment
-----------------
* Other: Online Survey


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Having been diagnosed with Type 1 Diabetes Mellitus Willing to participate in the study Participants whose native language is Turkish Exclusion Criteria: Unwilling to participate in the study Having a cognitive disorder Not being literate Individuals who do not have sufficient knowledge and functional levels to fill out the online form

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 65 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Patients with type 1 diabetes mellitus<br>Patients with Type 1 diabetes mellitus willing to participate in the study | Other: Online Survey<br>* Online surveys will be applied to all participants<br>|
| Healthy controls<br>Healthy controls without chronic disease willing to participate in the study | Other: Online Survey<br>* Online surveys will be applied to all participants<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Physical activity level | Physical activity level using International Physical Activity Questionnaire - Short Form (IPAQ-SF) will be evaluated. | Five minutes | 
| General Quality of life | Quality of life using Short Form Health Survey (SF-36) will be evaluated. | Ten minutes | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Depression | Depression using Hospital Anxiety and Depression Scale will be evaluated. | Three minutes | 
| Anxiety | Anxiety using Hospital Anxiety and Depression Scale will be evaluated. | Three minutes | 
| Self-reported hypoglycemia | It will be questioned how many times patients have had hypoglycemic attacks (<4 mmol/L and common symptoms) in the last 7 days. | Last seven day | 
| Loneliness | Loneliness using UCLA Loneliness Scale Short Form (ULS-8) will be evaluated. | Three minutes | 
| Hypoglisemia fear | Hypoglisemia fear using Hypoglisemia Fear Survey (HFS) will be evaluated. | Five minutes | 
| Dyspnea | Dyspnea during daily life activites using Modified Medical Research Dyspnea Scale will be evaluated. | Two minutes |